Health Industry Groups Press For Diagnostics Reform Bill
Executive Summary
Almost 50 stakeholder groups have signed onto a letter to US Congressional leadership that asks lawmakers to pass the VALID Act, which would update the country’s approach to diagnostic test regulation. Congress needs to pass a user fee package this month to ensure full FDA funding.
You may also be interested in...
‘Skinny’ User-Fee Reauthorization Would Leave Out Diagnostics Reform
A stripped-down version of the US FDA user-fee reauthorization package may be the best Congress can do before the August recess, but some say it won’t be enough.
Joint Mission: FDA And VA Partner On Device Development Initiative
The US Food and Drug Administration and the Veterans Health Administration are partnering to create tools that can help novel technology reach patients more quickly and easily.
Minute Insight: Thermo Fisher Gets FDA OK On Cancer Companion Diagnostic
The US FDA has approved additional indications for Thermo Fisher Scientific’s Oncomine Dx Target, allowing the companion diagnostic to be used to detect more varieties of lung and thyroid cancer.